INSIGHTS ON QUALITY CONTROL

• 8 Regulations Every Biotech & Pharma Quality Leader Must Know

  Navigate essential biotech and pharma regulations safely. Learn how unifying global standards streamlines audits and accelerates development schedules.

• Contamination Control Strategy With QRM Principles

  Contamination Control Strategies (CCS) have long been a main concept, but advancing requirements and regulatory expectations create a challenge. Learn how to be effective and compliant with your CCS.

• Empowering Glove Integrity Testing: Successful End User Training On The Esco IntelliGlove Tester (EIGT) In Bangladesh

  Advanced wireless testing ensures glove and barrier integrity in sterile manufacturing. These tools support ISO compliance and Annex 1 standards to strengthen contamination control.

• XR76 Introduction: 5 Key Features To Learn About

  Ensure quality compliance on high-speed lines with high-resolution inspection. Learn how to optimize contaminant detection and minimize costly false rejects.

• High-Throughput Pyrogen Testing In A Multimode Microplate Reader

  3/20/2026

  Explore a faster, high‑sensitivity approach to pyrogen detection that uses an NF‑κB reporter system to measure both endotoxin and non‑endotoxin contaminants to enable shorter workflows.

• CDMO Audit Coverage: Key Focus Areas And Compliance Objectives

  12/30/2025

  CDMO audits focus on compliance, quality, performance, and relationships to reduce risk, ensure clear documentation, and align customer expectations with CDMO capabilities.

• Platform Strategy For Improving Manufacturability And Efficacy In Bispecific Antibodies

  7/15/2026

  Novel bispecific antibody engineering overcomes assembly and manufacturability challenges, enabling scalable production while preserving therapeutic function, stability, purity, and product quality.

• 5 Hidden Risks In Early-Phase OSD Formulation Development

  8/31/2026

  Early formulation decisions in OSD development carry risks that may not surface until later stages, when the cost of course correction is significantly higher.

• Late‑Stage Progress In Excipients For Precision Nanomedicine

  5/6/2026

  View late‑stage development and GMP manufacturing of novel excipients for nanomedicines, emphasizing regulatory rigor, process optimization, analytics, and scale‑up for lipid‑based delivery systems.